In this study, we performed bulk RNA-seq and other experiments to elucidate the intertumor heterogeneity among BRCA1 deficient mammary tumors, and scRNA-seq of more than 20000 mammary cells and tumor cells to reveal the intratumor heterogeneity and gene expression variations during the mammary tumorigenesis process. The gene discussed is BRCA1; the disease is breast cancer.